Chimerix, Inc.
2505 Meridian Parkway
Durham
North Carolina
27713
United States
Website: http://www.chimerix-inc.com/
326 articles about Chimerix, Inc.
-
Chimerix, Inc. Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
11/8/2010
-
Chimerix, Inc.'s CMX001 Shows Potential for Strong Antiviral Activity in Critically-Ill Immunocompromised Transplant Patients With Adenovirus Infection
10/22/2010
-
Chimerix, Inc. to Present at 9th Annual Biotechnology Industry Organization (BIO) Investor Forum
9/29/2010
-
Chimerix, Inc. to Present at 12th Annual UBS Global Life Sciences Conference
9/17/2010
-
Chimerix, Inc.'s CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir
7/28/2010
-
Chimerix, Inc. Appoints Two New Vice Presidents to Clinical Management Team
7/21/2010
-
Chimerix, Inc. to Present at Upcoming Investor Conferences
6/2/2010
-
Chimerix, Inc. Initiates Phase 1 Study of CMX157
5/13/2010
-
Chimerix, Inc. Appoints Thomas Pitler, Ph.D., Vice President, Business Development
5/6/2010
-
Chimerix, Inc. Appoints Kenneth I. Moch President and Chief Executive Officer
5/4/2010
-
Chimerix, Inc. Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
3/9/2010
-
Chimerix, Inc. Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
2/5/2010
-
Chimerix, Inc. to Present at Two Upcoming Investor Conferences
11/12/2009
-
Chimerix, Inc. Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
11/6/2009
-
Chimerix, Inc. Raises $16.1 Million in Series E Financing
8/11/2009
-
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
7/16/2009
-
Chimerix, Inc. Joins International Network of Organizations to Cure Malaria
4/2/2009
-
Chimerix, Inc. Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
1/6/2009
-
Chimerix, Inc. Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
1/3/2008
-
Chimerix, Inc. Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection
12/11/2007